Novel device to diagnose and treat patients much faster

Scientists from Monash University have developed a new device that can rapidly screen the blood in just minutes to detec...

January 23, 2019 | Wednesday | News
Invitrocue declares changes in board

Invitrocue Limited, a leading healthcare bio-analytic solutions provider, announces the appointment of Dr. Steven Fang a...

January 9, 2019 | Wednesday | News
Immutep collaborates with CYTLIMIC

Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...

January 8, 2019 | Tuesday | News
Scientists discover a molecule that predicts patient's ability to survive melanoma

Doctors may be able to assess the survival rates of melanoma patients following the discovery of a molecule that allows ...

January 2, 2019 | Wednesday | News
Patrys’s drug suppresses breast cancer brain metastases, increases survival

Singapore -  Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinica...

December 24, 2018 | Monday | News
Australian researchers to start clinical trials for dementia ultrasound treatment

Safety testing of a pioneering ultrasound technique that could delay the effects of dementia will begin in Brisbane late...

December 20, 2018 | Thursday | News
NeuClone discloses its sixth biosimilar candidate of Pertuzumab

NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing h...

December 18, 2018 | Tuesday | News
Novotech CRO launches largest Oracle TMMCS in APAC

Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has i...

December 17, 2018 | Monday | News
“Diabetic kidney disease could overwhelm our health systems”: Dr Richard Lipscombe

Globally, the diabetic nephropathy market is witnessing significant growth due to rise in the incidence of diabetes and ...

December 17, 2018 | Monday | Opinion
Mayne Pharma receives FDA approval of Tolsura

Australia-based Mayne Pharma announced that the US FDA has approved the New Drug Application (NDA) for Tolsura 65mg...

December 12, 2018 | Wednesday | News
Sienna embarks on ambitious M&A strategy

Singapore - ASX-listed, cancer diagnostics company, Sienna, has emerging cancer diagnostics in sight as it embarks on M&...

December 11, 2018 | Tuesday | News
APLIDIN gets world-first approval for Multiple Myeloma

Multiple myeloma patients from Australia will have world-first access to a new first-in-class drug developed to treat th...

December 11, 2018 | Tuesday | News
Australian researchers develop novel technology for cancer detection

A group of researchers from the University of Queensland, Australia has developed a new method that will enable quick an...

December 5, 2018 | Wednesday | News
BlackBerry to help improve digital infrastructure for healthcare

Singapore – BlackBerry Limited announced it has become a HIMSS Analytics Certified Consultant to help address the ...

December 3, 2018 | Monday | News
Osprey awarded purchasing agreement for DyeVert PLUS

Singapore – Osprey Medical announced that its DyeVert Plus Contrast Reduction System was awarded a group purchasin...

December 3, 2018 | Monday | News
Health Care Originals announces strategic alliance with Healthport for Australia, NZ

Health Care Originals (HCO) announces its strategic alliance with Healthport. HCO is a leading manufacturer of medical w...

November 28, 2018 | Wednesday | News
Admedus appoints Matthew McDonnell as interim CFO

Medical technology company Admedus  has appointed former KPMG partner Matthew McDonnell as its interim CFO. With ov...

November 26, 2018 | Monday | News
Phebra announces new UK subsidiary company

Leading Australian pharmaceutical firm Phebra has announced the expansion of its international operations, with the esta...

November 21, 2018 | Wednesday | News